- Home
- PGNY vs PRCT Comparison
PGNY vs PRCT Comparison
Compare PGNY & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PGNY | PRCT |
|---|---|---|
| Founded | 2008 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PGNY | PRCT |
|---|---|---|
| Price | $20.77 | $27.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | $27.90 | ★ $51.13 |
| AVG Volume (30 Days) | ★ 1.4M | 1.2M |
| Earning Date | 02-26-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.96 | N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | ★ $1,268,689,000.00 | $299,907,000.00 |
| Revenue This Year | $11.63 | $48.30 |
| Revenue Next Year | $9.52 | $29.44 |
| P/E Ratio | $33.99 | ★ N/A |
| Revenue Growth | 11.41 | ★ 50.07 |
| 52 Week Low | $17.98 | $26.66 |
| 52 Week High | $28.75 | $70.80 |
Technical Indicators
Market Signals| Indicator | PGNY | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 30.59 | 40.94 |
| Support Level | $20.75 | $27.62 |
| Resistance Level | $21.75 | $30.02 |
| Average True Range (ATR) | 0.85 | 1.65 |
| MACD | -0.26 | 0.01 |
| Stochastic Oscillator | 11.18 | 28.13 |
Price Performance
Historical ComparisonAbout PGNY Progyny Inc.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.